Cite
Baker A, Clarke L, Donovan P, et al. Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia. Trials. 2021;22(1):918doi: 10.1186/s13063-021-05890-6.
Baker, A., Clarke, L., Donovan, P., P J Ungerer, J., Hartel, G., Bruxner, G., Cocchi, L., Gordon, A., Moudgil, V., Robinson, G., Roy, D., Sohal, R., Whittle, E., & Scott, J. G. (2021). Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia. Trials, 22(1), 918. https://doi.org/10.1186/s13063-021-05890-6
Baker, Andrea, et al. "Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia." Trials vol. 22,1 (2021): 918. doi: https://doi.org/10.1186/s13063-021-05890-6
Baker A, Clarke L, Donovan P, P J Ungerer J, Hartel G, Bruxner G, Cocchi L, Gordon A, Moudgil V, Robinson G, Roy D, Sohal R, Whittle E, Scott JG. Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia. Trials. 2021 Dec 13;22(1):918. doi: 10.1186/s13063-021-05890-6. PMID: 34903265.
Copy
Download .nbib